Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...
Illumina secures CMS reimbursement for TruSight Oncology Comprehensive, expanding access to precision oncology: San Diego Thursday, January 22, 2026, 17:00 Hrs [IST] Illumina, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback